TidalHealth has garnered national attention for its involvement in a clinical trial for a new therapy that repairs air sacs in the lungs of patients recovering from COVID-19. In this episode of On Point, RJ Wilkinson, Director of Respiratory Care at TidalHealth Peninsula Regional, explains how TidalHealth is supplying 40 percent of the data for this national trial and talks about his team's commitment to 'adapt and overcome' challenges associated with COVID-19.
